HEMPVANA MAXIMUM STRENGTH PAIN RELIEF TOPICAL ANESTHETIC- lidocaine cream

Hempvana Maximum Strength Pain Relief Topical Anesthetic by

Drug Labeling and Warnings

Hempvana Maximum Strength Pain Relief Topical Anesthetic by is a Otc medication manufactured, distributed, or labeled by Telebrands Corp, Neutraderm, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient

Lidocaine 5%

Purpose

Lidocaine 5%...........Local Anesthetic

Uses

For the temporary relief of local and anorectal discomfort associated with anorectal disorder or inflammation.

Warnings

For external use only

Allergy alert:If prone to allergic reaction from aspirin or salicylates, consult a doctor before use.

When using this product

• do not exceed the recommended daily dosage unless directed by a doctor.
• use only as directed. Read and follow all directions and warnings on this label.
• do not put this product into the rectum by using finger or any mechanical device or applicator.

Stop use and ask a doctor if

• condition worsens or does not improve within 7 days
• in case of bleeding
• symptom being treated does not subside or if redness, irritation, sweeling, pain, or other symptoms develop or increase. Certain persons can develop allergic reactions to ingredients in this product.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children and pets.If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• Adults:When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth, before application of this product to affected area.
• Apply to the affected area up to 6 times a day
• Children under 12 years of age:consult a doctor.

Other information

• Do not use if seal is broken or missing

Inactive ingredients

Water/Aqua/Eau, Ethylhexyl Stearate, Butylene Glycol, Dimethicone, Stearic Acid, Caprylic/Capric Triglyceride, Cannabis Saliva (Hemp) Seed Oil, Glyceryl Stearate, PEG-100 Stearate, Cetearyl Alcohol, Helianthus Annuus (Sunflower) Seed Oil, Curcuma Longa (Turmeric) Root Extract, Allantoin, Glycerin, Tocopheryl Acetate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Phenoxyethanol, Caprylyl Glycol, Ethylhexylglycerin, Hexylene Glycol, Sodium Hydroxide, Disodium EDTA

Questions?

Call (855) 877-4503 (M-F, 9am-5pm EST)

PRINCIPAL DISPLAY PANEL

Hempvana

Maximum Strength Pain Relief Topical Anesthetic Cream

5% Lidocaine anorectal cream

+Hemp Seed Oil For Moisturization

Odor Free!

Net Wt. 3 oz (85 g)

INGREDIENTS AND APPEARANCE

HEMPVANA MAXIMUM STRENGTH PAIN RELIEF TOPICAL ANESTHETIC 
lidocaine cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 73287-026
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE	5 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
CANNABIS SATIVA SEED OIL (UNII: 69VJ1LPN1S)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
TURMERIC (UNII: 856YO1Z64F)
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
PEG-100 STEARATE (UNII: YD01N1999R)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
GLYCERIN (UNII: PDC6A3C0OX)
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)
ALLANTOIN (UNII: 344S277G0Z)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)
SUNFLOWER SEED (UNII: R9N3379M4Z)
WATER (UNII: 059QF0KO0R)
STEARIC ACID (UNII: 4ELV7Z65AP)
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)
ETHYLHEXYL STEARATE (UNII: EG3PA2K3K5)
HEXYLENE GLYCOL (UNII: KEH0A3F75J)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 73287-026-01	1 in 1 CARTON	02/17/2023
1		85 g in 1 JAR; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M015	02/17/2023

Labeler - Telebrands Corp (177266558)

Establishment
Name	Address	ID/FEI	Business Operations
Neutraderm, Inc.		146224444	manufacture(73287-026)